Ginkgo Bioworks Holdings, Inc. Annual Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Ginkgo Bioworks Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Ginkgo Bioworks Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$375K, a 1605% decline year-over-year.
  • Ginkgo Bioworks Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$352K, a 97.6% increase year-over-year.
  • Ginkgo Bioworks Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was -$71K, a 99.5% increase from 2022.
  • Ginkgo Bioworks Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was -$15M, a 915% decline from 2021.
  • Ginkgo Bioworks Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was -$1.48M, a 178% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$71K +$15M +99.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$15M -$13.5M -915% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$1.48M -$3.37M -178% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $1.89M +$1.87M +8486% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-13
2019 $22K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.